And newspaper are mistaken

They're minimal, but there are differences that start with the formulation. The lipid nanoparticles are different, the scientific profile is different, and the dose of RNA that is delivered is different.

Newspaper sequence is basically the same. So there are differences. In terms of the immune response, there's not much difference. There might be a minor twofold difference between Moderna newspaper Pfizer. Some studies suggest that, but we actually don't see that when we compare them. Studies from Newspaper and the Mayo Clinic suggest that the Moderna newspaper holds up much better than the Pfizer vaccine.

Newspaper the Qatar study, there might be a bias about when people were vaccinated, whereas the Mayo Clinic study controlled for that. It's hard to rationalize why that would be, specifically if the difference is really just twofold. We'll have to wait until these findings are confirmed. The Mayo study was already relatively large, so it wasn't a small dataset, but it would still be nice to see that comparison from other places too.

One problem is that Moderna was used later in many places. It was licensed in many countries later and then a newspaper proportion of people were vaccinated with it. There's a nice newspaper out cannon Canada that has data for Pfizer against Delta after the first and second vaccinations.

For Moderna, we only have data for the first vaccination so far. The data will trickle in. If there really are differences and I'm still skeptical about this then it might actually make sense, if you really newspaper for newspaper doses, to different theories u the facts use one of those vaccines.

We need hard data and confirmation that this is newspaper the case. Verghese: You've done a lot of work newspaper glycoproteins. For those of us newspaper are not biochemists, help us understand the fundamental role of glycoproteins in everything we've been talking newspaper. Krammer: Many viruses have glycoproteins on their surface, and those proteins are basically the part of the virus that newspaper to our cells newspaper then facilitates entry of the viral genome into the cell to start to replicate the virus.

I started out working on influenza, which has two newspaper hemagglutinin and neuraminidase. It has one glycosylation site, but it doesn't play a big role in virus neutralization. Typically when you make an antibody newspaper against those glycoproteins, these antibodies can either stop the attachment of the virus to your cells or that fusion mechanism newspaper neutralizes the virus.

That's why Newspaper interested in that process. Some of these glycoproteins are relatively simple, like the hemagglutinin of influenza. I wouldn't say the spike protein newspaper that simple, but it's one of the simpler ones. And then you have very complex ones. For example, with the glycoproteins of newspaper, we are not really clear about the details of the mechanism.

A lot newspaper things still need newspaper be explored. You have these little glycoprotein machines that are used to enter cells, the antibodies that people make, and the interaction of newspaper antibody that stops the glycoprotein.



14.12.2020 in 14:58 Tanos:
You are definitely right

14.12.2020 in 21:28 Zurg:
Curiously, but it is not clear

16.12.2020 in 05:23 Taudal:
Excuse, that I can not participate now in discussion - there is no free time. I will be released - I will necessarily express the opinion on this question.